By Wendy Diller
In February of this year, the FDA approved the first radioimmunotherapy in the US, Idec Pharmaceuticals Corp. 's ibritumomab tiuxetan (Zevalin), a monoclonal antibody attached to a radioisotope indicated...
Imaging in its Heyday: Clinical Applications (Part II)
As scientific innovation in molecular imaging explodes, experts believe the big payoff will be in clinical, rather than research, applications. But absent validating clinical data, businesses remain hesitant to jump into the field.